To Top

Search By Topic

Biologics – Large Molecule

77 Articles available
Biosimilars

Amgen To Co-Develop Biosimilars for Chinese Market with Simcere Pharmaceutical Group

PAO-M10-17-NI-007
Biosimilar

FDA Approves First Biosimilar Treatment for Multiple Cancers

PAO-M09-17-NI-030
Acquisition

Catalent Acquires Cook Pharmica

PAO-M09-17-NI-028
Biosimilar

Another Biosimilar Gets FDA Nod

PAO-M09-17-NI-011
Partnership

Collaboration Seeks Novel Pancreatitis Therapies

PAO-M08-17-NI-037
Biologics

New FDA Draft Guidance on Manufacturing Changes for Biologics Issued

PAO-M08-17-NI-034
Capacity Expansion

Boehringer Ingelheim Expands Biologics Manufacturing Capacity in California

PAO-M08-17-NI-007
CDMO

Biopharmaceutical Manufacturing Goes Mainstream

PAP-Q2-17-FA-004
Excipients

Celanese on the Road to BIO: Excipients In Biologics

Dr. Donald Loveday – Customer Applications Director, Pharma and Medical, Celanese. View more about Celanese on the Road to BIO.

PTV-M06-17-CL-010
Biologics

Sanofi Will Increase Investments in Biologics

PAO-M06-17-NI-012
Biologics

Pharma Revs Up Cancer-Fighting CAR T-Cell Therapy

MCP-M06-17-NI-001
Biologics

The Road to Biologics’ Continued Success

PAP-Q2-17-EN-001
Biologics

Biologics: Driving Force in Pharma

PAP-Q2-17-NO-001
Biologics

Propagating a Full Spectrum of Services for ADC Development and Manufacture

PAP-Q2-17-CL-007
Biologics

Making Strides: Biologics Push Forward

PAP-Q2-17-FA-001
Biologic

Q: If You Could Have One Piece of Biologic Manufacturing Equipment Improved, What Would It Be and Why?

PAP-Q2-17-RT-001
Roundtable

Q: What is the Most Significant Recent Advancement in Downstream Bioprocessing Technology? Why is it so Important?

PAP-Q2-17-RT-002
HPAPI

The Introduction of Robotics: Creating a Truly Sterile Environment

Jason S. Collins, Director, Process Architecture, IPS

 

PTV-M03-17-IN-001
Biologics

Biosimilar Era Begins to Blossom

PAO-M04-17-NI-027
CDMO

Bioprocessing Capacity is in High Demand

PAO-M04-17-NI-022
CDMO

Cobra Biologics Invests in Gene Therapy

PAO-M04-17-NI-020
CDMO

Grand River Has Come a Long Way

Tom Ross, President and CEO, Grand River

PTV-M11-16-AP-026
Biologics

Dan Peizer Reveals Catalant’s Newest Acquisition

Dan Peizer, Global Director of Corporate Marketing, Catalent

PTV-M11-16-AP-027
Biologics

Keeping it Clean

Malcolm McLaughlin, Vice President Of Business Development, Alconox

PTV-M11-16-AP-005
Biologics

Hiring Top Talent in Pharma

Robert Hoyle, President, Global Talent Solutions

PTV-M11-16-AP-009
Biologics

GermFree Bio Introduces Mobile GMP Cleanroom Platform

PAO-M04-17-NI-009
CDMO

Sanofi, Lonza Invest in Large-Scale Biologics Partnership

PAO-M03-17-NI-007
//Fix for text overflow in cards